Latest Conference Articles

Nanette Silverberg, MD, takes a deep dive into the importance of early intervention and gave an overview of topical care for patients of all ages with vitiligo.

A poster from the RAD Virtual Conference reviewed the relationship between Black and DHH patients and the shared disparities these populations face.

Catch up on coverage from this week's virtual Revolutionizing Atopic Dermatitis and Revolutionizing Vitiligo conferences.

David Rosmarin, MD, presented new and upcoming pipeline updates for the treatment of vitiligo at the Revolutionizing Vitiligo Virtual Conference.

At the 2023 RAD Virtual Conference, Chovatiya presented a session titled, "Living the Cream."

The poster was presented at the 2023 Revolutionizing Atopic Dermatitis (RAD) Virtual Conference.

Christopher Bunick, MD, PhD, presented the research during a late-breaking research session during the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

Jennifer Etienne shared her experiences during the shared decision-making patient panel of the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

A poster from the 2023 Revolutionizing Atopic Dermatitis Conference revealed a link between AD, impaired oral health, and oral dysbiosis.

Alan Irvine, MD, DSc, discusses his Revolutionizing Atopic Dermatitis session and exciting advances in AD.

The promising data on upadacitinib was presented at the 2023 Revolutionizing Vitiligo Virtual Conference.

Andrew F. Alexis, MD, MPH, shared insights into using JAK inhibitors as part of the treatment revolution in atopic dermatitis at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Atoosa Kourosh, MD, MPH, delves into opportunities for allergists and dermatologists to collaborate, her approach to cases, and patient resources.

Ama Alexis, MD, shared the importance of recognizing diverse presentations of atopic dermatitis at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Kwatra presented on the unmet need for itch improvement in patients with skin of color.

Session at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.

Marcella R. Aquino details issues in differential diagnosis for rashes that mimic allergic skin conditions at the ACAAI Annual Meeting.

Karen S. Hsu Blatman, MD, shared key insights on biologics at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Kamran H. Imam, MD, hopes to unlock insights into the atopic disease burden among Native American populations.

Late-breaking data adds important safety and efficacy data for leukotriene receptor antagonists augmentation in chronic urticaria treatment.

What are some of the challenges and triumphs in using biologics for atopic dermatitis? Abby L. Allen, RN, NP, shares insights at the American College of Allergy, Asthma and Immunology 2023 Annual Scientific Meeting.

The second full day of the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting was filled with new data, important insights, and more.

Research at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting discusses the impact of an educational program on improving care.

Todd L. Sack, MD, shares practice management tips for going green at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.

Poster presented at American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting yields positive results for adults and children 2 years age and up.

Amanda L. Michaud, PA-C, shares insights on difficult to control chronic spontaneous urticaria at the ACAAI Annual Scientific Meeting.

Catch up on highlights from the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting.